We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Zaire Ebola Virus Molecular Detection Kit Launched

By LabMedica International staff writers
Posted on 14 Jan 2015
A new in vitro diagnostics (IVD) CE-marked kit for real-time PCR based detection of the Zaire Ebolavirus, the strain responsible for the current outbreak in West Africa, has recently been released.

The new assay, “FTD Ebola,” is from Fast-Track Diagnostics (Luxembourg), a leader in the design, development, and manufacture of infectious disease detection kits. More...
FDT Ebola is based on an easy-to-use one-tube mastermix for multiplex real-time PCR with internal control, so clinicians can deliver fast, highly accurate diagnoses leading to greater efficiency in the treatment of patients.

“Supporting infectious disease detection in the developing world has always been a priority for Fast-Track Diagnostics,”said Dr. William Carman, CEO of Fast-Track Diagnostics, “We offer substantial discounts to these countries, as well as to anyone involved in relevant research projects. Therefore we are delighted to expand our extensive portfolio with this new addition.” Fast-Track Diagnostics includes a commitment to research and diagnostic laboratories in the developing world and its kits are used by the GABRIEL network for projects funded by the Wellcome Trust and the Bill and Melinda Gates Foundation.

Fast-Track Diagnostics has one of the broadest ranges available for single and multiplex PCR kits for infectious diseases. Its assays are validated on clinical samples. Kits are available for over 100 different pathogens— including viruses, bacteria, fungi, and parasites—many in multiplex syndrome panel format for commonly faced conditions, including respiratory infections, gastroenteritis, meningitis, and infections of the immunosuppressed. Assays are compatible with many standard laboratory real-time PCR cyclers and extraction methods, and are in routine daily use in over 100 laboratories worldwide.

The Ebola PCR kit from Fast-Track Diagnostics is currently not US FDA approved.

Related Links:

Fast-Track Diagnostics 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.